Derivatives and Hedging Activities - Schedule of Pre-tax Effect of Cash Flow Hedges, Net Investment Hedges and Fair Value Hedges on the Consolidated Statements of Operations, Recorded in Interest and Other Financing Expense, Net (Details) - Reclassification out of Accumulated Other Comprehensive Income - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net		$ 540	$ 2,964	$ 6,846	$ 8,875
Cross-currency swaps | Fair Value Hedging | Accumulated Net Gain Loss From Fair Value Hedges Attributable To Parent
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net	[1]	(995)	122	146	369
Cross-currency swaps | Net Investment Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net		450	489	1,439	1,479
Interest Rate Swap | Cash Flow Hedging | Accumulated Net Gain Loss From Cash Flow Hedges Attributable To Parent | Interest and other financing expense, net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net		1,311	2,363	5,359	7,037
Foreign currency forward contracts | Cash Flow Hedging | Accumulated Net Gain Loss From Fair Value Hedges Attributable To Parent | Interest and other financing expense, net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net		(92)	0	36	0
Foreign currency forward contracts | Fair Value Hedging | Accumulated Net Gain Loss From Fair Value Hedges Attributable To Parent | Cost of sales
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest and other financing expense, net		$ (134)	$ (10)	$ (134)	$ (10)

[1] Net of amount that is excluded from effectiveness testing. The amount of gain, excluded from effectiveness testing, reclassified from AOCL into income for the three months ended March 31, 2025 and 2024 was $104 and $122, respectively. The amount of gain, excluded from effectiveness testing, reclassified from AOCL into income for the nine months ended March 31, 2025 and 2024 was $351 and $369, respectively.